Filter by: patients
Home > Community Treatment Reports and Side Effects > Emtricitabine-Tenofovir Treatment Report
What is Emtricitabine-Tenofovir?

Emtricitabine and tenofovir is an antiviral medication that prevents human immunodeficiency virus (HIV) from reproducing in your body. Emtricitabine and tenofovir treats HIV, which causes acquired immunodeficiency syndrome (AIDS).

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 295 69 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 7 1 Efficacy_cant_tell
Support immune health 5 1 Efficacy_cant_tell
Increase effect of another treatment 3 0
General health 2 0
Fatigue 1 0

See all 342 patients currently taking Emtricitabine-Tenofovir

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 3
Moderate
 17
Mild
 15
None
 36

Commonly reported side effects, conditions, and hospitalizations associated with Emtricitabine-Tenofovir

Diarrhea 11
Loss of energy 7
Headaches 6
Dizziness 3
Fatigue 2
Sickness 2
See all 23 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Emtricitabine-Tenofovir. See all 23 dosages ►

  daily 1 daily 1 other daily 1 mg daily 100 mg daily 200 mg-300 mg m,w,f 200 mg daily 245 mg daily 300 mg daily 200 mg-300 mg daily
  32 Number of Patients: 32 12 Number of Patients: 12 3 Number of Patients: 3 4 Number of Patients: 4 3 Number of Patients: 3 2 Number of Patients: 2 12 Number of Patients: 12 3 Number of Patients: 3 12 Number of Patients: 12 242 Number of Patients: 242  

Reported Stop Reasons

Why Patients Stopped Taking Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 25   Doctor's advice: 44%
Other 15   Other: 26%
Side effects too severe 7   Side effects too severe: 12%
Course of treatment ended 6   Course of treatment ended: 11%
Did not seem to work 3   Did not seem to work: 5%
Expense 3   Expense: 5%
Personal research 2   Personal research: 4%
Change in health plan coverage 1   Change in health plan coverage: 2%
Not indicated 1   Not indicated: 2%

See all 54 patients who’ve stopped taking Emtricitabine-Tenofovir

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Emtricitabine-Tenofovir

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Emtricitabine-Tenofovir

Always
 60 85%
Usually
 8 11%
Sometimes
 1 1%
Never
 2 3%

Burden

Difficulty being on treatment

Burden of Emtricitabine-Tenofovir

Very
 1 1%
Somewhat
 3 4%
A little
 11 15%
Not at all
 56 79%

Cost

Paid out of pocket

Cost of Emtricitabine-Tenofovir

$200+
 1 2%
$100-199
 2 4%
$50-99
 4 8%
$25-49
 5 10%
< $25
 36 73%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.